Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
44.71
+0.87 (1.98%)
At close: Nov 25, 2025, 4:00 PM EST
43.90
-0.81 (-1.81%)
After-hours: Nov 25, 2025, 5:51 PM EST
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $4.24 billion as of November 25, 2025. Its market cap has decreased by -21.21% in one year.
Market Cap
4.24B
Enterprise Value
3.20B
1-Year Change
-21.21%
Ranking
Category
Stock Price
$44.71
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $4.24B, an increase of 652.34%. That is a compound annual growth rate of 31.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 4.16B | -12.27% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.73M | -26.50% |
| Dec 31, 2021 | 1.34B | 188.40% |
| Dec 31, 2020 | 464.53M | -23.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |